130 related articles for article (PubMed ID: 21477256)
1. Evaluating the activity of the RNA polymerase inhibitor myxopyronin B against Staphylococcus aureus.
Moy TI; Daniel A; Hardy C; Jackson A; Rehrauer O; Hwang YS; Zou D; Nguyen K; Silverman JA; Li Q; Murphy C
FEMS Microbiol Lett; 2011 Jun; 319(2):176-9. PubMed ID: 21477256
[TBL] [Abstract][Full Text] [Related]
2. Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase.
Lira R; Xiang AX; Doundoulakis T; Biller WT; Agrios KA; Simonsen KB; Webber SE; Sisson W; Aust RM; Shah AM; Showalter RE; Banh VN; Steffy KR; Appleman JR
Bioorg Med Chem Lett; 2007 Dec; 17(24):6797-800. PubMed ID: 17980587
[TBL] [Abstract][Full Text] [Related]
3. Activity of and development of resistance to corallopyronin A, an inhibitor of RNA polymerase.
Mariner K; McPhillie M; Trowbridge R; Smith C; O'Neill AJ; Fishwick CW; Chopra I
Antimicrob Agents Chemother; 2011 May; 55(5):2413-6. PubMed ID: 21321139
[TBL] [Abstract][Full Text] [Related]
4. Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation.
Doundoulakis T; Xiang AX; Lira R; Agrios KA; Webber SE; Sisson W; Aust RM; Shah AM; Showalter RE; Appleman JR; Simonsen KB
Bioorg Med Chem Lett; 2004 Nov; 14(22):5667-72. PubMed ID: 15482944
[TBL] [Abstract][Full Text] [Related]
5. Frequency, spectrum, and nonzero fitness costs of resistance to myxopyronin in Staphylococcus aureus.
Srivastava A; Degen D; Ebright YW; Ebright RH
Antimicrob Agents Chemother; 2012 Dec; 56(12):6250-5. PubMed ID: 23006749
[TBL] [Abstract][Full Text] [Related]
6. RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus.
O'Neill A; Oliva B; Storey C; Hoyle A; Fishwick C; Chopra I
Antimicrob Agents Chemother; 2000 Nov; 44(11):3163-6. PubMed ID: 11036042
[TBL] [Abstract][Full Text] [Related]
7. A new class of small molecule RNA polymerase inhibitors with activity against rifampicin-resistant Staphylococcus aureus.
Arhin F; Bélanger O; Ciblat S; Dehbi M; Delorme D; Dietrich E; Dixit D; Lafontaine Y; Lehoux D; Liu J; McKay GA; Moeck G; Reddy R; Rose Y; Srikumar R; Tanaka KS; Williams DM; Gros P; Pelletier J; Parr TR; Far AR
Bioorg Med Chem; 2006 Sep; 14(17):5812-32. PubMed ID: 16759869
[TBL] [Abstract][Full Text] [Related]
8. Anti-staphylococcal activity and mode of action of clofazimine.
Oliva B; O'Neill AJ; Miller K; Stubbings W; Chopra I
J Antimicrob Chemother; 2004 Mar; 53(3):435-40. PubMed ID: 14762055
[TBL] [Abstract][Full Text] [Related]
9. Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.
Oefner C; Bandera M; Haldimann A; Laue H; Schulz H; Mukhija S; Parisi S; Weiss L; Lociuro S; Dale GE
J Antimicrob Chemother; 2009 Apr; 63(4):687-98. PubMed ID: 19211577
[TBL] [Abstract][Full Text] [Related]
10. Total synthesis of RNA-polymerase inhibitor ripostatin B and 15-deoxyripostatin A.
Tang W; Prusov EV
Angew Chem Int Ed Engl; 2012 Apr; 51(14):3401-4. PubMed ID: 22378642
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of restoration of sensitivities of resistant Staphylococcus aureus isolates by using cefuroxime and clavulanic acid in combination.
Jalil A; Niazi ID; Khan SU
J Ayub Med Coll Abbottabad; 2008; 20(2):28-30. PubMed ID: 19385452
[TBL] [Abstract][Full Text] [Related]
12. Novel small molecule inhibitors targeting the "switch region" of bacterial RNAP: structure-based optimization of a virtual screening hit.
Sahner JH; Groh M; Negri M; Haupenthal J; Hartmann RW
Eur J Med Chem; 2013 Jul; 65():223-31. PubMed ID: 23711833
[TBL] [Abstract][Full Text] [Related]
13. Access to skipped polyene macrolides through ring-closing metathesis: total synthesis of the RNA polymerase inhibitor ripostatin B.
Winter P; Hiller W; Christmann M
Angew Chem Int Ed Engl; 2012 Apr; 51(14):3396-400. PubMed ID: 22337614
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel bacterial RNA polymerase inhibitors: pharmacophore-based virtual screening and hit optimization.
Hinsberger S; Hüsecken K; Groh M; Negri M; Haupenthal J; Hartmann RW
J Med Chem; 2013 Nov; 56(21):8332-8. PubMed ID: 24112046
[TBL] [Abstract][Full Text] [Related]
15. Increased antibacterial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV.
Yun HJ; Min YH; Jo YW; Shim MJ; Choi EC
Int J Antimicrob Agents; 2005 Apr; 25(4):334-7. PubMed ID: 15784314
[TBL] [Abstract][Full Text] [Related]
16. Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).
Mendes RE; Sader HS; Jones RN
Int J Antimicrob Agents; 2010 Oct; 36(4):374-9. PubMed ID: 20598860
[TBL] [Abstract][Full Text] [Related]
17. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus.
Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S
J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562
[TBL] [Abstract][Full Text] [Related]
19. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.
Torrico M; Aguilar L; Sevillano D; Giménez MJ; Alou L; González N; Cafini F; Cleeland R; Prieto J
Int J Antimicrob Agents; 2011 Apr; 37(4):332-8. PubMed ID: 21388792
[TBL] [Abstract][Full Text] [Related]
20. [Heliomycin suppression of RNA synthesis in a cell-free system].
Korolev PN; Polin AN; Bulgakova VG; Silaev AB
Antibiotiki; 1978 Mar; 23(3):242-7. PubMed ID: 345959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
